Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page adds a new revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer/history section.
    Difference
    0.2%
    Check dated 2025-12-22T01:20:46.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Added a new revision label 'Revision: v3.3.2' in the history and removed the previous label 'Revision: v3.3.1'. This is a minor system update.
    Difference
    0.1%
    Check dated 2025-11-30T10:17:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page history lists a new Revision: v3.3.1 and the removal of Revision: v3.2.0 in the version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T07:55:09.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Removal of the government funding notice banner from the page header; the core study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-16T05:50:48.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version 13 (2025-06-13) was added, showing updates to the Study Status and Recruitment Status in the record history.
    Difference
    0.1%
    Check dated 2025-11-01T23:59:02.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.
    Difference
    12%
    Check dated 2025-10-04T03:15:52.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.